Clinical trial registry record

Evaluation of Soy Isoflavones on Skin Ageing Parameters

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated April 10, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06047145
Last registry update
April 10, 2025
Status
Completed
Phase
Phase not reported
Sponsor
The Archer-Daniels-Midland Company
Enrollment
66
Countries
France
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · PREVENTION · TRIPLE
Evidence population
Human clinical study registration
Participants
66
Population
FEMALE · 40 Years to 65 Years
Duration
2023-10-27 to 2024-02-26
Intervention
soy isoflavones; Placebo
Comparator
placebo
Outcomes measured
Change in Crow's Feet wrinkles (Ra) — day 0, day 84; Change in Crow's Feet wrinkles (Ra) — day 0, day 42; Change in Crow's Feet wrinkles (Rz) — day 0, day 42, day 84; Change in Crow's Feet wrinkles (Rt) — day 0, day 42, day 84; Change in under eye wrinkles (Ra) — day 0, day 42, day 84; Change in under eye wrinkles (Rt) — day 0, day 42, day 84; Change in under eye wrinkles (Rz) — day 0, day 42, day 84; Change in skin hydration — day 0, day 42, day 84; Change in skin colour — day 0, day 42, day 84; Change in skin barrier function — day 0, day 42, day 84; Subject satisfaction — day 42, day 84; Adverse events — day 0, day 42, day 84
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Skin ageing · 100%Title contains controlled term: skin ageing. Abstract contains controlled term: skin ageing. Source terminology contains: skin ageing. Title supplies longevity context: ageing. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

skin aging
Open primary sourceExport JSON